EBM :: Evidence-based Medicine Newsletter
Evidence-based Medicine
ST-segment elevation myocardial infarction: efficacy of MGuard, an embolic protection stent as a function of delay to reperfusion
The ability of stent implantation to improve indexes of reperfusion may depend on the time to reperfusion in acute ST-segment elevation myocardial infarction ( STEMI ) and may also vary with stent typ …
No evidence supports the routine use of beta-blockers for secondary prevention after stroke or TIA
Stroke affects 15 million people per year worldwide. Despite recent developments in acute stroke treatment, prevention remains very important. Stroke has a high rate of recurrence; therefore secondary …
Survivors of myocardial infarction: intake of dietary fiber is inversely associated with all cause mortality
A prospective cohort study has evaluated the associations of dietary fiber after myocardial infarction ( MI ) and changes in dietary fiber intake from before to after myocardial infarction with all ca …
Statin therapy is effective at reducing the risk of contrast-induced acute kidney injury with coronary angiography
Contrast-induced acute kidney injury is an adverse outcome resulting from radiocontrast medium exposure during coronary angiography and percutaneous coronary intervention. A systematic search was c …
Inoperable patients with severe aortic stenosis: transcatheter aortic valve replacement linked to better survival and functional status
The long-term outcomes of transcatheter aortic valve replacement ( TAVR ) in inoperable patients with severe aortic stenosis remain unknown. In the Placement of Aortic Transcatheter Valves ( PARTNE …
Prevention of venous thromboembolism in critically ill patients: cost-effectiveness of Dalteparin vs unfractionated Heparin
Venous thromboembolism ( VTE ) is a common complication of acute illness, and its prevention is a ubiquitous aspect of inpatient care. A multicenter blinded, randomized trial compared the effectivenes …
High-dose fish oil does not reduce atrial fibrillation recurrence, inflammation, and oxidative stress
Recent trials of fish oil for the prevention of atrial fibrillation ( AF ) recurrence have provided mixed results. Notable uncertainties in the existing evidence base include the roles of high-dose fi …
–
Coloro che sono GIA’ ISCRITTI ad altre Newsletter Xagena possono accedere al Pannello di Controllo al sito XagenaWeb.it inserendo l’indirizzo e-mail con il quale ricevono le Newsletter e la Password personale [ RIPORTATA IN FONDO A OGNI NEWSLETTER ] E’ importante confermare la modifica cliccando sul tasto SALVA MODIFICA